Loading…
3billion is a company that maximizes diagnostic yields for rare diseases using automated AI re-analysis technology with daily data updates. The firm offers genetic testing services including enhanced exome sequencing, genome sequencing, and AI variant prioritization through its GEBRA™ platform.
AI named 3billion from December 2025 to January 2026.